首页> 外文期刊>Biological & pharmaceutical bulletin >Salidroside inhibits endogenous hydrogen peroxide induced cytotoxicity of endothelial cells
【24h】

Salidroside inhibits endogenous hydrogen peroxide induced cytotoxicity of endothelial cells

机译:红景天苷抑制内源性过氧化氢诱导的内皮细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Salidroside, a phenylpropanoid glycoside isolated from Rhodiola rosea L., shows potent antioxidant property. Herein, we investigated the protective effects of salidroside against hydrogen peroxide (H_2O_2)- induced oxidative damage in human endothelial cells (EVC-304). EVC-304 cells were incubated in the presence or absence of low steady states of H _2O_2 (3-4 μM) generated by glucose oxidase (GOX) with or without salidroside. 3(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH) assays were performed, together with Hoechst 33258 staining and flow cytometric analysis using Annexin-V and propidium iodide (PI) label. The results indicated that salidroside pretreatment attenuated endogenous H _2O_2 induced apoptotic cell death in EVC-304 cells in a dose-dependent pattern. Furthermore, Western blot data revealed that salidroside inhibited activation of caspase-3, 9 and cleavage of poly(ADP-ribose) polymerase (PARP) induced by endogenous H2O2. It also decreased the expression of Bax and rescued the balance of pro- and anti-apoptotic proteins. All these results demonstrated that salidroside may present a potential therapy for oxidative stress in cardiovascular and cerebrovascular diseases.
机译:红景天苷,一种从玫瑰红景天中分离出来的苯基丙烷糖苷,显示出有效的抗氧化性能。本文中,我们研究了红景天苷对人内皮细胞(EVC-304)中过氧化氢(H_2O_2)诱导的氧化损伤的保护作用。在有或没有红景天苷的情况下,在存在或不存在由葡萄糖氧化酶(GOX)生成的H _2O_2(3-4μM)低稳态的情况下孵育EVC-304细胞。进行了3(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT),超氧化物歧化酶(SOD),丙二醛(MDA)和谷胱甘肽(GSH)测定以及Hoechst 33258染色和流动使用Annexin-V和碘化丙啶(PI)标签进行细胞计数分析。结果表明,红景天苷预处理以剂量依赖的方式减弱了内源性H _2O_2诱导的EVC-304细胞凋亡。此外,蛋白质印迹数据显示,红景天苷抑制内源性H2O2诱导的caspase-3、9的激活和聚(ADP-核糖)聚合酶(PARP)的裂解。它还降低了Bax的表达,并挽救了促凋亡和抗凋亡蛋白的平衡。所有这些结果表明,红景天苷可能是心血管和脑血管疾病中氧化应激的潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号